Histone demethylases and regulation of chromatin and transcription in eukaryotes

真核生物中组蛋白去甲基化酶以及染色质和转录的调节

基本信息

  • 批准号:
    8460446
  • 负责人:
  • 金额:
    $ 28.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-13 至 2016-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The N-terminal tails of histone proteins are heavily decorated by a plethora of covalent modifications including methylation, acetylation, phosphorylation, sumoylation and ubiquitylation. These modifications work together to generate appropriate chromatin templates for a host of important nuclear events, including transcription, DNA replication, recombination and repair. A defect in the DNA damage signaling and repair machinery can lead to the development of cancer, and therefore understanding the mechanisms that control this pathway has important health implications. In recent years, although significant progress has been made in our understanding of histone modifications in transcriptional regulation, much less is known about how these modifications impact the DNA damage response (DDR) and the precise molecular mechanisms by which histone- modifying enzymes regulate the DDR pathway. In the past funding period, we discovered that the histone demethylase LSD1, which thus far is thought to function only as a transcriptional regulator, also plays an evolutionarily conserved role in the DDR. Loss of LSD1 does not affect the expression of repair genes; furthermore, chromatin immunoprecipitation places LSD1 at DNA damage sites, suggesting a direct involvement of LSD1 in this process. Importantly, loss of LSD1 results in impaired histone H2A/H2A.X ubiquitylation, with subsequent loss of 53BP1 recruitment, a molecule important for DNA damage repair. In this application, we propose to test our hypothesis that a novel crosstalk exists between histone H3K4 demethylation and H2A/H2A.X ubiquitylation important for the DDR by identifying molecular mechanisms by which LSD1 regulates histone H2A/H2A.X ubiquitylation. Given that LSD1 mediates demethylation of mono- and di-methylated histone H3K4, we will also investigate whether H3K4 methylation dynamics is generally important for the DDR by determining whether demethylases for the tri-methylated H3K4 as well as a host of H3K4 methyltransferases also play a role in the DDR. Lastly we will begin to address the question of whether there is a specific constellation of histone modifications at DNA damage sites that induce a distinct chromatin domain for DNA repair, by delineating the histone modification landscape and the responsible enzymes at DNA damage sites. We anticipate that new paradigms to emerge from the proposed studies, significantly impacting our understanding of epigenetic regulation in the DDR.
描述(由申请人提供): 组蛋白的N端被大量的共价修饰修饰,包括甲基化、乙酰化、磷酸化、总甲基化和泛素化。这些修饰共同作用,为一系列重要的核事件生成适当的染色质模板,包括转录、DNA复制、重组和修复。DNA损伤信号和修复机制的缺陷可能导致癌症的发展,因此了解控制这一途径的机制具有重要的健康意义。近年来,尽管我们对组蛋白修饰在转录调控方面的理解已经取得了重大进展,但对于这些修饰如何影响DNA损伤反应(DDR)以及组蛋白修饰酶调控DDR途径的确切分子机制还知之甚少。在过去的资助期间,我们发现组蛋白去甲基酶LSD1,到目前为止被认为只作为转录调节因子,在DDR中也扮演着进化上保守的角色。LSD1的缺失不影响修复基因的表达;此外,染色质免疫沉淀将LSD1放置在DNA损伤位置,表明LSD1直接参与了这一过程。重要的是,LSD1的丢失会导致组蛋白H2A/H2A.X泛素化受损,从而导致53BP1募集的丢失,53BP1是DNA损伤修复的重要分子。在这个应用中,我们建议通过识别LSD1调节组蛋白H2 A/H 2A.X泛素化的分子机制来验证我们的假设,即组蛋白H3K4去甲基化和H 2A/H 2A.X泛素化之间存在着对DDR重要的新的串扰。鉴于LSD1介导组蛋白H3K4单甲基化和双甲基化的去甲基化,我们还将通过确定三甲基化的H3K4去甲基酶以及一系列H3K4甲基转移酶是否也在DDR中发挥作用,来研究H3K4甲基化动力学是否对DDR普遍重要。最后,我们将通过描绘组蛋白修饰的图景和DNA损伤部位的负责酶,开始解决DNA损伤部位是否存在特定的组蛋白修饰星座,从而诱导DNA修复的独特染色质结构域。我们预计,拟议的研究将出现新的范式,显著影响我们对DDR中表观遗传调控的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yang Shi其他文献

Yang Shi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yang Shi', 18)}}的其他基金

Epigenetic regulation of cellular plasticity and cancer cell fate
细胞可塑性和癌细胞命运的表观遗传调控
  • 批准号:
    9390257
  • 财政年份:
    2017
  • 资助金额:
    $ 28.19万
  • 项目类别:
Investigation of roles and mechanisms of DNA and histone modification networks in trans-generational epigenetic inheritance
DNA和组蛋白修饰网络在跨代表观遗传中的作用和机制研究
  • 批准号:
    9753026
  • 财政年份:
    2016
  • 资助金额:
    $ 28.19万
  • 项目类别:
Investigation of roles and mechanisms of DNA and histone modification networks in trans-generational epigenetic inheritance
DNA和组蛋白修饰网络在跨代表观遗传中的作用和机制研究
  • 批准号:
    9335409
  • 财政年份:
    2016
  • 资助金额:
    $ 28.19万
  • 项目类别:
Novel epigenetic mechanisms in neuronal development and cognitive function
神经元发育和认知功能的新表观遗传机制
  • 批准号:
    9114161
  • 财政年份:
    2012
  • 资助金额:
    $ 28.19万
  • 项目类别:
Novel epigenetic mechanisms in neuronal development and cognitive function
神经元发育和认知功能的新表观遗传机制
  • 批准号:
    8527849
  • 财政年份:
    2012
  • 资助金额:
    $ 28.19万
  • 项目类别:
Novel epigenetic mechanisms in neuronal development and cognitive function
神经元发育和认知功能的新表观遗传机制
  • 批准号:
    8925143
  • 财政年份:
    2012
  • 资助金额:
    $ 28.19万
  • 项目类别:
Novel epigenetic mechanisms in neuronal development and cognitive function
神经元发育和认知功能的新表观遗传机制
  • 批准号:
    8371566
  • 财政年份:
    2012
  • 资助金额:
    $ 28.19万
  • 项目类别:
Hsp90, NOS3 and Cardioprotection
Hsp90、NOS3 和心脏保护
  • 批准号:
    7879747
  • 财政年份:
    2009
  • 资助金额:
    $ 28.19万
  • 项目类别:
Hsp90, NOS3 and Cardioprotection
Hsp90、NOS3 和心脏保护
  • 批准号:
    7332187
  • 财政年份:
    2006
  • 资助金额:
    $ 28.19万
  • 项目类别:
Histone demethylases and regulation of chromatin and transcription in eukaryotes
真核生物中组蛋白去甲基化酶以及染色质和转录的调节
  • 批准号:
    8289432
  • 财政年份:
    2006
  • 资助金额:
    $ 28.19万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.19万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了